• English
  • Sign In
  • Contact Us
Catalog Products » SARS-CoV-2 Nucleocapsid Antibody (hIgM2003), Human Chimeric

SARS-CoV-2 Nucleocapsid Antibody (hIgM2003), Human Chimeric

Synonyms 2019-nCoV Nucleocapsid Antibody (hIgM2003), SARS-CoV-2 NP Antibody
Description SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). Nucleocapsid Protein is a most abundant structure protein of the coronavirus which is associated with nucleic acid.
SARS-CoV-2 Nucleocapsid Antibody (hIgM2003), Human Chimeric is produced from cell culture in vitro under conditions free from animal-derived components.
Conjugation Unconjugated
Purification Affinity chromatography
Clone hIgM2003 (monoclonal antibody)

Subclass Recombinant human IgM
Concentration 1 mg/ml, supplied in PBS, pH 7.4, containing 0.02% sodium azide.
Specificity The product is specific for SARS-CoV-2 Nucleocapsid protein.
Storage Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. Avoid repeated freezing and thawing cycles.
Note GenScript can customize this product per customer's request including product size, buffer components, etc.

Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
ELISA detection: 0.1-10 µg/ml
Other applications: user-optimized

Notice there is no results found, you can visit "Citations Database" for other results.

For more documents, please visit "Technical Support".

Cat. No. A02059
Size Price
100 µg $429.00
1 mg Quote